Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, will showcase its Arrow® brand interventional radiology portfolio at the 1st Annual Congress of the European Society for Vascular Medicine (ESVM) to be held in Potsdam, Germany on May 10 - 12, 2015.

During the event, Teleflex will highlight both the Arrow® GPSCath® Balloon Dilatation Catheter featuring innovative VisioValve™ technology over a 0.014 guidewire - now for below-the-knee interventions, and the Super Arrow-Flex® Sheath Introducer.

The Arrow® GPSCath® Catheter is a specialty two-in-one device that is indicated for percutaneous transluminal angioplasty (PTA) in the peripheral vasculature, including iliac, femoral, popliteal, infrapopliteal and renal arteries allowing the physician to conduct angioplasty and inject fluid (targeted angiogram specifically at lesion site) while maintaining catheter and guidewire position. Below-the-knee interventions can be complex undertakings, requiring multiple devices, numerous procedural steps and significant procedural time. The Arrow® GPSCath® Catheter now offers a solution by combining multiple required features into one device.

The Super Arrow-Flex® Sheath Introducer gives complete vascular access, thanks to its wire-reinforced design and construction. From easy insertion and handling to the highly visible radiopaque tip, the Super Arrow-Flex® Sheath Introducer is designed to deliver optimal performance from start to finish. With a wide range of sheath sizes and lengths, the Super Arrow-Flex® Sheath Introducer gives the physician flexibility of choice for multiple vascular applications.

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care, urology and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Wayne, PA, Teleflex employs approximately 12,200 people and serves healthcare providers worldwide. Additional information about Teleflex can be obtained from the company's website at teleflex.com.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, Arrow, Arrow-Flex, GPSCath and VisioValve are trademarks or registered (in the U.S. and/or other countries) trademarks of Teleflex Incorporated or its affiliates. © 2015 Teleflex Incorporated. All rights reserved.

Teleflex IncorporatedJake ElguiczeTreasurer and Vice President, Investor Relations610-948-2836orMartina Teichmann-ZindlerDirector Marketing Communications International+49 (0)7151-406-538martina.teichmann@teleflex.com

Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Teleflex Charts.
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Teleflex Charts.